DEI Should Have Ended Harvard’s ‘Elite’ Status 60 Years Ago (Or More), by Joy Pullmann
June 4, 2025Daily Scripture Readings and Meditations: Consecrated in God’s Truth
June 4, 2025
By Kate Quiñones, CNA, June 3, 2025
CNA Staff, Jun 3, 2025 / 14:20 pm – A top official at the U.S. Food and Drug Administration (FDA) confirmed on Monday that the organization will conduct a review of the abortion drug mifepristone following several recent studies challenging the safety of the drug.
FDA Commissioner Marty Makary said he is “committed” to conducting the review in a June 2 letter addressed to Missouri Sen. Josh Hawley, who has been an outspoken advocate for reviewing abortion pill safety regulations.
“As with all drugs, FDA continues to closely monitor the post-marketing safety data on mifepristone for the medical termination of early pregnancy,” Makary wrote. …